A Deeper Look at Clinical Trial Outcomes

Show Description +

A panel of retina experts share their perspective on how they interpret findings from the phase 3 clinical trial with ranibizumab-nuna compared to reference ranibizumab.

Posted: 4/14/2023

A Deeper Look at Clinical Trial Outcomes

A panel of retina experts share their perspective on how they interpret findings from the phase 3 clinical trial with ranibizumab-nuna compared to reference ranibizumab.

Posted: 4/14/2023

Resources

Biosimilars in Retinal Disease Management

View Resource

About Biogen

One of the world’s first global biotechnology companies, Biogen, was founded in 1978 by Charles Weissmann, Heinz Schaller, Sir Kenneth Murray, and Nobel Prize winners Walter Gilbert and Phillip Sharp. Biogen is commercializing biosimilars and transforming the standard of care for patients in several areas of high unmet need.